AMNEAL PHARMACEUTICALS, INC. Other Assets, Miscellaneous, Noncurrent
AMNEAL PHARMACEUTICALS, INC. (AMRX) had Other Assets, Miscellaneous, Noncurrent of $7.79 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › and Other Assets
us-gaap:OtherAssetsMiscellaneousNoncurrent · last filed 2026-08-06
- 2026-06-30: Other Assets, Miscellaneous, Noncurrent $7.79M.
- 2025-12-31: Other Assets, Miscellaneous, Noncurrent $3.11M.
- 2024-12-31: Other Assets, Miscellaneous, Noncurrent $5.28M.
- 2023-12-31: Other Assets, Miscellaneous, Noncurrent $7.13M.
| Period end | Other Assets, Miscellaneous, Noncurrent |
|---|---|
| 2026-06-30 | $7.79M 10-Q · filed 2026-08-06 |
| 2025-12-31 | $3.11M 10-Q · filed 2026-08-06 |
| 2024-12-31 | $5.28M 10-K · filed 2025-02-28 |
| 2023-12-31 | $7.13M 10-K · filed 2025-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |